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Antioxidant activityThis study analyzes the action of sulfated polysaccharides, fucans, from algae Lobophora variegata on
zymosan-induced arthritis in rats. Groups of fucans, obtained after acetone fractionation (0.3–2.0 volumes),
were denominated F0.3, F0.5, F0.8, F1, F1.5, and F2. The results that F1 contained a high yield in relation to
other fractionated fucans. Chemical and structure analysis of F1 was performed by nuclear magnetic
resonance (NMR) and infrared (IR) spectroscopies. The in vitro antioxidant activities of the fraction F1 were
also observed. Thus, 2 mg/mL of F1 inhibited the phosphomolybdate in the total antioxidant activity assay.
The EC50 values were 0.3 mg/mL and 0.12 mg/mL for superoxide and hydroxyl radicals, respectively. Fucan F1
(25, 50, and 75 mg/kg by body weight), diclofenac sodium (10 mg/kg), and L-NAME (25 mg/kg) were
administered intraperitoneally (i.p.) in rats, according to body weight of different groups of animals (n=6).
After 6 h, analyses of cell inﬂux and nitrite levels were conducted. Then after 96 h, analysis of edema and
concentration of serum TNF-α was carried out along with histopathological analysis. F1 at 25, 50, and
75 mg/kg i.p. by body weight reduced cell inﬂux in 52.1–96.7% and nitric oxide level in 27.2–39% compared
with the control group. The reduction of edema and serum TNF-α was observed at 50 mg/kg i.p. (pb0.001).
These results suggest that this heterofucan from the brown algae L. variegata has potential anti-inﬂammatory
activity in acute zymosan-induced arthritis in rats and that antioxidant activity promotes modulation in the
cellular redox state.io Grande do Norte, Centro de
lgado Filho, 3000 – Campus
razil. Tel.: +55 84 3215 3416.
evier OA license.© 2011 Elsevier B.V. Open access under the Elsevier OA license.1. Introduction
Fucans are polysaccharides classiﬁed into homofucans, formed by
fucose and sulfate, and heterofucans, which contain other sugars and
uronic acids, in addition to sulfate and fucose (1,2). Fucans from
brown algae are usually heterogeneous and branched, with irregular
patterns of sulfatation (4). Fucoidans are considered by some
researchers as sulfated homofucans, although they contain small
amounts of other sugars. These compounds are involved in a number
of pharmacological activities, such as anticoagulant, antithrombotic,
antioxidant, and inﬂammatory activities (3), regulation of cytokine
production, and P and L-selectin blocking (1).
Arthritis, an inﬂammatory disease of the joints, is caused by several
factors, including chemical, biological and immunological factors. It is
characterized according to the articular structure affected. Thus,affection of the synovial membrane after intra-articular administra-
tion of zymosan in rats promotes the emergence of inﬂammatory
parameters similar to those of rheumatoid arthritis (RA), a systemic
inﬂammatory disease of autoimmune etiology, characterized by
chronic and erosive synovitis of peripheral joints (5,6). Recent studies
point to imbalances in redox processes in the inﬂammatory response
to RA, which would account for worsening of the pathology due to
uncontrolled oxidative stress (7). This etiology may be explained by
genetic defects, as well as immunoregulation and mechanism defects
that lead to tissue damage, including the imbalance between oxidants
and antioxidants, in favor of oxidants, which would result in disorder
of both signaling and molecular damage control (8,9).
In synovitis, inﬂammatory cells respond with increased cytokine
production and intense formation of free radicals, such as reactive
oxygen species, leading to oxidative stress that ampliﬁes the
inﬂammatory process, causing articular destruction, edema, and
pain (10). Studies demonstrated that, although inﬂammation is the
persistent characteristic, the generation of high levels of free radicals
in the inﬂamed joint and the deﬁcit levels of antioxidant systems are
involved in this pathology (11).
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homofucans in intra-articular inﬂammation. The present study
focused on structural characterization, antioxidant activity, and the
articular inﬂammation model in Wistar rats of a heterofucan from the
brown seaweed Lobophora variegata.
2. Materials and methods
2.1. Materials
For this study, materials were obtained as follows: acetone and
sodium chloride (Reagen Quimibrás Indústrias Químicas S.A., Rio de
Janeiro, RJ, Brazil); sulfuric acid (Merck, Darmstadt, Germany);
coomasie brilliant blue R 250, α-(L)-fucose, D-galactose, L-xylose,
glucuronic acid, D-mannose, NADPH, nitroblue tetrazolium, phenazin
metasulfate, nitrate reductase (Sigma Aldrich, St. Louis, USA); agarose
(Bio Rad Laboratories); 2% xylazine chloridrate and 5% ketamine
chloridrate (Köning do Brasil, Ltda).
2.2. Sulfated polysaccharide extraction from L. variegata
L. variegata in dried powder form was suspended in 2 volumes of
0.15 MNaCl and the pH of themixturewas adjusted to 8.0 with NaOH.
Fifteen milligrams of maxatase per gram of seaweed was added for
proteolytic digestion. The reaction mixture was then incubated for
24 h at 60 °C and ﬁltered through cheesecloth. The polysaccharides of
the ﬁltrate were further puriﬁed and fractionated by increasing the
acetone concentration (0.3, 0.5, 0.8 1.0, 1.5, and 2.0v).
2.3. Chemical analyses
Total sugars were estimated by phenol-sulfuric acid reaction (12)
using a standard galactose curve. Sulfate was measured after
hydrolysis (6 N HCl, 100 °C, 4 h) using the turbidimetric method
(13) with sodium sulfate as standard. Proteins were estimated by the
Bradford reagent (14).
Monosaccharidic compositions of the fractions were determined
by high-performance liquid chromatography (HPLC) (15). The poly-
mers were hydrolyzed (2 M HCl, 100 °C, 2 h) and their sugar content
was determined by high performance liquid chromatography (HPLC)
with a refractive index detector using LichroCART®250-4. As
references, the following sugars were analyzed: arabinose, galactose,
glucose, fucose, mannose, rhamnose, and xylose. The mobile phase
consisted of a mixture of 0.1 mol/l KH2PO4 (pH 10)-acetonitrile
(80:20). The ﬂow-rate was 1.0 mL/min and column temperature was
30 °C. Sugar was identiﬁed by a comparison with reference sugars
(rhamnose, fucose, arabinose, xylose, mannose, galactose, glucose,
galacturonic acid, glucuronic acid, mannuronic acid, andN-acetyl-β-D-
glucosamine).
2.4. Electrophoresis
Aliquots of the fractions (5 μg) were applied to 0.6% agarose gel
prepared with 0.05 M 1,3 diaminopropane acetate buffer, pH 9.0. The
compounds were then ﬁxed in the gel with 0.01% N-cetyl-N-N-N
trimethylamonium bromide for 4 h. The gel was dried and stained
with 0.1% toluidine blue (16).
2.5. Infrared spectroscopy and NMR spectroscopy
The infrared spectra were measured with a Perkin–Elmer
instrument in KBr pellets containing 5 mg of the sample dissolved
in D2O. The 1H-nuclear magnetic resonance spectra were obtained in a
Bruker AMX 500 MHz and the 13C-NMR spectra were obtained in a
Bruker AM-400WB 500 spectrometer at 60 °C.2.6. Total antioxidant activity assay
Total antioxidant activity was determined using 1 mL of reagent
solution, containing ammonium molybdate (4 mM), sulfuric acid
(600 mM) and sodiumphosphate (28 mM), and 0.1 mL of test solution
at different concentrations (0.0156–5 mg/mL) in tubes, which were
then sealed and incubated at 95 °C for 90 min. After cooling to ambient
temperature, the activities were spectrophotometrically monitored
for Mo+6 formation from Mo+5, forming phosphomolybdenum,
which shows maximum absorbance at 695 nm. Concentrations of
ascorbic acid were used to obtain a standard curve and total
antioxidant capacity was expressed in ascorbic acid equivalents (17).
2.7. Reducing power assay
The reducing power of fraction F1 was determined based on the
method proposed by Yen and Chen (1995). One mL aliquots, with
different concentrations of F1 (0.156–5 mg/mL), were mixed with
2.5 mL of 0.2 M of sodium phosphate buffer, pH 6.6, and 2.5 mL of 1%
(w/v) potassium ferricyanide. The mixture was incubated at 50 °C for
20 min. Next, 2.5 mL of 10% (w/v) trichloroacetic acid was added to
the mixture, which was centrifuged at 1500 g for 10 min. The
supernatant (2.5 mL) was diluted with 2.5 mL of distilled water and
added together with 0.5 mL of 0.1% (w/v) ferric chloride. In this
reaction, K3Fe(CN)6 was reduced by the sample and K4Fe(CN)6 was
formed, which in turn reacted with Fe+³, giving rise to Prussian blue,
which showed maximum absorbance at 700 nm (18). Concentrations
of ascorbic acid were used to obtain a standard curve and the reducing
power of F1 was expressed as ascorbic acid equivalents.
2.8. Superoxide radical scavenging assay
Superoxide radicals were generated in 3 mL of tris–HCl (16 mM,
pH 8.0), containing 78 μM of NADH (reduced form), 50 μM of
nitroblue tetrazolium (NBT), 10 μM of metasulfate phenazine, and
assorted concentrations of polysaccharides (0.078–5 mg/mL). The
reaction was detected by monitoring absorbance at 560 nm.
The white reaction was free of NADH and substituted by tris–HCl.
The removal rate (RR) of superoxide radicals was calculated using the
following equation: RR (%)=(1−Aa/Ac)*100, where Aa is the mean
of the absorbances obtained in readings of speciﬁc sample concen-
tration and Ac is the mean of absorbances obtained in readings of
control reaction mediums (19).
2.9. Hydroxyl radical scavenging assay
The deoxyribose colorimetric method was used to determine
removal activity of hydroxyl radicals (•OH). The following compounds
were used: 200 μL of KH2PO4–KOH (100 mM), 200 μL of deoxyribose
(15 mM), 200 μL of FeCl3 (500 mM), 100 μL of EDTA (1 mM), 100 μL of
ascorbic acid (1 mM), 100 μL H2O2 (10 mM), and 100 μL of sample
(0.025–2 mg/mL). The mixture was incubated at 37 °C for 1 h. After
the incubation period, 1 mL of 1% (w/v) thiobarbituric acid (TBA) and
1 mL of 2.8% (w/v) trichloroacetic acid (TCA) were added. The
solution was heated in a double-boiler at 80 °C for 20 min, developing
a pink color, characteristic of the malondialdehyde bond, the product
of deoxyribose oxidation, and TBA. Absorbance was determined at
532 nm. The removal rate (RR) of hydroxyl radicals was calculated
using the following formula: RR (%)=[1−(Ao/A)]×100, where Ao is
the mean absorbances of control readings (without deoxyribose) and
A is the mean absorbances of sample readings (20).
2.10. Cytotoxic assessment of F1
Venous blood was collected in the presence of heparin and then
processed. The blood was diluted with the same volume of sterile
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(HISTOPAQUE-1077) at a proportion of 3 mL for each 5 mL of
heparinized blood. This mixture was then centrifuged at 1450 g for
30 min at 25 °C. Peripheral mononuclear blood cells were carefully
aspirated and transferred to another tube. Twenty mL of the RPMI
medium at 4 °C was added to the cells, and suspension was
centrifuged at 1600 g for 15 min at 4 °C. This procedure was repeated
twice. Next, the supernatant was removed and 2 mL of RPMI was
added to the precipitate. A 10 μL aliquot was mixed with 40 μL of
Turck solution for microscopic visualization of the cells, which were
counted in a Neubauer chamber. After the cell count, an aliquot of the
suspension was removed and the concentration was adjusted with
RPMI, such that the ﬁnal solution was 1×106 cells/mL.
The cells were cultured in 96-plate wells containing 1×106 cells/
well. F1 concentrations were prepared from sterile stock solutions and
serially diluted in RPMI-1640 medium, obtaining a ﬁnal volume of
100 μL in each well. Thus, ﬁnal concentrations were between 0.5 and
1.0 mg/mL. Next, MTT stain was added (10 μL of MTT per 100 μL of
medium), then dissolved in PBS buffer at 5 mg/mL, ﬁltered, and
sterilized. The plates were kept in humid atmosphere containing 5%
CO2 at 37 °C for 24 and 48 h. Living cells are capable of converting the
MTT into a blue compound called formazan. After the necessary reaction
time, acid/isopropanol was added to eachwell to stabilize the formazan
crystals. The readings were carried out on an ELISA reader at 540 nm
(21).
2.11. Zymosan-induced joint inﬂammation
Wistar rats, aged 3–4 months (190–240 g), were housed in cages
under controlled illumination (12–12 h light-dark cycle) at 22–23 °C
and supplied food and water ad libitum. The negative control group
(n=6) received a 50 μL intra-articular (i.a.) administration of 0.9%
saline solution, while the positive control group and the other groups
received 50 μL of zymosan (20 μg/μL) diluted in 0.9% saline (22).
Inﬂammation was induced with zymosan after the animals had been
anesthetized with 1 mL of xylasine chloridrate (5 mg/kg) and
ketamine chloridrate (10 mg/kg). After 1 h of induction, F1 (25, 50
and 75 mg/kg), sodium diclofenac (5 mg/kg), a nonsteroidal anti-
inﬂammatory drug (NSAID), and NG-nitro-L-arginine methyl ester
(L-NAME) (25 mg/kg) were intraperitoneally (i.p.) administered. In
the ﬁrst experiment, after 6 h of arthritis induction, the animals were
anesthetized with chloral hydrate (400 mg/kg i.p.) and then killed by
decapitation. The synovial ﬂuid was then collected to analyze cell
inﬂux and quantify nitric oxide. In a second experiment F1 (25, 50 and
75 mg/kg), sodium diclofenac (5 mg/kg) and L-NAME (25 mg/kg)
were intraperitoneally administered, 1, 24, 48, and 72 h after
induction, and at 96 h (5th day) the animals were anesthetized with
chloral hydrate (400 mg/kg i.p.), exsanguinated, and killed. Joint
edema was measured and blood was collected daily to analyze
serum TNF-α. After the animals were killed, the synovial membrane
was removed for histopathological analysis.
2.12. Analysis of cell inﬂux and determination of nitric oxide
(NO) production
Intra-articular lavageﬂuidwas obtained by aspiration of the rat knee
joint using sodium phosphate as buffer (0.15 M and pH 7.4) and EDTA
(0.01 M). Total cell count was done in a Neubauer chamber using 20 μL
of the lavage ﬂuid diluted in 400 μL of Turk solution. After the articular
lavage ﬂuid was centrifuged at 600×g for 8 min, the supernatant was
used to evaluate nitrite (NO2−) and nitrate (NO3−) production, indicators
of NO synthesis. The NO3− of the exudate was reduced to NO2− by
incubation with the nitrate reductase enzyme (670 μm/mL) in the
presence of NADPH (160 μM) at room temperature for 3 h. Nitrite
concentration was then measured by the Griess reaction, with the
addition of 100 μL of this reagent to 100 μL of the sample. Absorbance at540 nm was measured in an ELISA reader. Nitrite concentrations were
calculated by comparing sample absorbance with standard solutions of
sodium nitrite prepared in saline solution (23).
2.13. Edema evaluation
The edema was analyzed by measuring the thickness of injured
knee joints using the caliper method (Lotus ABS digital caliper, REF:
5571, scale: 0–150 mm). The ﬁrst measure was taken immediately
before arthritis induction and the second immediately before
administration of the treatment compounds. Edema thickness was
always measured at the height of the kneecap on each of the 5 days of
the experiment.
2.14. Determination of serum TNF-α
To determine serum TNF-α (BD OptEIA kit), 0.1 mL of animal serum
was used. Identiﬁcation of TNF-αwas carried out using the ELISAmethod,
at a wavelength of 450 nm. A standard curve with recombinant TNF-α
was created to determine the effect of polysaccharides on this cytokine.
2.15. Histopathological analyses of the synovial membrane
The synovial membranes were collected and preserved in 10%
formaldehyde. This was followed by routine processing until
placement in parafﬁn blocks, which were subsequently sectioned
with a 4-mmmicrotome steel razor for hematoxylin and eosine (H&E)
staining (24). The histological cuts of the synovial membrane in rats
were examined under optical microscope to analyze proliferation of
intrascapsular ﬁbrous tissue, the adipose tissue, cell inﬁltrate,
villosities, and giant cells (25,26). The histological ﬁndings then
underwent semiquantitative analysis.
2.16. Statistical analyses
Analysis of variance (ANOVA) with a signiﬁcance level of pb0.05
and the Tukey–Kramer test were used to determine differences in the
values obtained by the control and experimental groups.
3. Results
3.1. Extraction and chemical analyses
After collection, washing and drying at 37 °C under constant air
current, the algal material, consisting of 40 g of dry seaweed, was
weighed. Differential precipitation in acetone fractionated the poly-
saccharides of L. variegata, resulting in 6 fractions denominated as
F0.3, F0.5, F0.8 F1, F1.5, and F2. Total fraction (TF) was considered
“crude polysaccharide,” and the other fractions were obtained from it.
The resulting fractions showed differences in yield and in the amounts
of proteins, total sugars, and sulfate (Table 1).
Sample yield was an important requirement for use in experi-
mental models. Fraction F1, in addition to exhibiting greater yield
than the others (51.9%), showed higher polysaccharide (46.6%) and
sulfate (22.7%) content and lower amounts of protein (0.12%).
Fractions F0.3, F0.5, and F0.8 exhibited a low yielding, proteins
(0.2% and 0.42%, respectively) and alginic acids (not shown). For this
reason, fraction F1 was chosen to study its effects in experimental
models of arthritis and antioxidant activity.
The agarose gel electrophoresis and 1,3 diaminopropane acetate
buffer, pH 9, of the above-mentioned fractions, demonstrated the
polydisperse due several molecular weight. The metachromatic char-
acteristics is common in sulfatedpolysaccharides fromalgal and animals
as fucans and heparin respectively.Metachromasy, color reddish blue or
pink, is a characteristic change in the color of staining carried out in
biological tissues.
Table 1
Yield, amount of proteins assessed using the standard albumin curve, percentage of
sugars using the standard galactose curve, and sulfate percentage with the standard
sodium sulfate curve (1 mg/mL) of fractions extracted from Lobophora variegata,
obtained from the differential precipitation with acetone. *SD (standard deviation).
Fraction Yielding (%) Protein (%) Sugars (%) Sulfate (%)
FT – 0.13±0.02 41.4±0.63 21.5±3.4
F0.3 2.1 0.2±0.03 26.2±0.09 26.4±1.8
F0.5 2.7 0.42±0.09 29.4±0.09 36.6±2.5
P0.8 16.5 0.18±0.06 44.5±0.12 29.5±2.3
Fl 51.9 0.12±0.08 46.6±0.36 22.7±2.1
F1.5 25.3 0.23±0.02 52.6±0.09 17.1±2.6
F2 1 0.15±0.04 40.8±0.18 13.2±1.6
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Chromatographic analysis, using high performance liquid chro-
matography of acid hydrolysate from the polysaccharide fraction (F1),
demonstrated the presence of fucose, galactose, and glucose sugars,
withmolar ratio of 1: 1.4: 1.9, respectively, containing traces of xylose.
3.3. Infrared spectroscopy of polysaccharide F1 from the seaweed L. variegata
In Fig. 1A, the 3734 and 3671 cm−1 bands showed axial deformation
of O–H, corresponding to the intermolecular and intramolecular
hydrogen bond. The bands at 3075 and 2885 cm−1 were attributed to
axial deformations of the C–H for the secondary (–CH2–) and primary
(–CH3) bonds, respectively. A band that was attributed to the angular
deformations of the C–H Bond of the primary and secondary carbons
was observed between 1630 and 1400 cm−1. F1 showed an intense
absorption band at 1238 cm−1 common to the sulfate ester. AnFig. 1. A—Infra red spectrum of fraction F1 from L. variegata, B—H¹-Nadditional sulfate absorption band at 850 cm−1 revealed the presence
of sulfate in the axial position of C-4, common to fucans (2,27).
3.4. Nuclear magnetic resonance spectrum
The 1H nuclear magnetic resonance (NMR) spectrum of the fucan
was poorly resolved, but signals at 1.7 ppm corresponded to the
methyl group of the fucose (not shown). The anomeric resonances at
5.26–5.28 and 4.08–4.41 conﬁrmed the presence of anomeric signals
(Fig. 1B). The analysis of 13C-NMR spectroscopy is shown in Fig. 1C.
Like other algal fucans (28), it has a very complex 13C NMR spectrum,
which was difﬁcult to interpret thoroughly. The peaks at 103.5–
104.0 ppm corresponded to β-D-galactose residues and at 97.2–
97.8 ppm toα-L-fucose residues. The signal at 16.5 ppm corresponded
to CH3 of fucoses (29).
3.5. Antioxidants activities “in vitro”
Fraction F1 showed total antioxidant activity (Fig. 2A) in relation to
ammonium molybdate. A concentration range between 0.039 and
10mg/mL was used for F1, where maximum activity was observed
above 5 mg/mL. The antioxidant activity of ascorbic acid was obtained
and comparedwith the activity of fraction F1 from L. variegata. Reducing
activity of ascorbic acid used as standard, reached a peak at 0.25 mg/mL.
A comparison between the activity (absorbance) of 5 mg/mL in F1 and
the maximum activity of ascorbic acid at 0.25 mg/mL showed a
reduction rate of 75%.
The reducing power assay, which has ascorbic acid as standard,
demonstrated that F1 was capable of reducing the reaction system
(Fig. 2B). Thus, it promoted a reduction of Fe+3 to Fe+2, forming the
Prussian blue complex, indicating high reducing power (30). The
maximum reducing power of F1 (2.5 mg/mL) was compared with theMR spectrum of fraction F1. C—C¹³-NMR spectrum of fraction F1.
Fig. 2. A—Total antioxidant capacity of polysaccharides (0.039–10 mg/mL of F1) from the brown seaweed L. variegata. B—Reducing power activity of F1 in an oxidant system.
C—Antioxidant activity curve of L. variegata in a superoxide-generating generating system with different concentrations of Fraction 1. D—Inhibitory activity of hydroxyl radical
formation in a system generated from this free radical.
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at a concentration of 2.5 mg/mL, showed a reducing rate of 85.7%. The
reducing capacity of F1 served as a convincing indicator of its potential
antioxidant potential.
The superoxide radical is a species produced in a phenazine
metasulfate/NADH system with NBT reduction. Fig. 2C shows the
percentage inhibition of superoxide radicals at different concentra-
tions of F1. A maximum inhibition percentage of 94% of these radicals
at 2.5 mg/mL of F1 was observed. Although the superoxide radical has
weak oxidating action, its conversion to hydroxyl radicals has a very
negative effect on living systems.
Fig. 2D shows that the hydroxyl radical was inhibited with the
increase in F1 concentration, exhibiting inhibitory activity of around
98% when used at a concentration of 8 mg/mL.
The EC50 (50% of efﬁcient concentration) values of the antioxidant
assays were obtained for fraction F1 of L. variegata. The EC50 calculated
represents the concentration of the sample required to provide 50% of
the inhibitory activity of free radicals. Thus, 2 mg/mL of F1 inhibited
50% of phosphomolybdate in the total antioxidant activity assay,
while in the reducing power assay, the EC50 of F1 was 0.675 mg/mL. In
the removal assays of the superoxide and hydroxyl radicals, the EC50
values were 0.3 mg/mL and 0.12 mg/mL, respectively.3.6. Cytotoxicity of F1
The formation of formazan by living cells can be detected after 24 h
of incubation with F1 (0.5 and 1 mg/mL). The cytotoxicity assay
revealed that the concentrations used (0.5 and 1 mg/mL) showed nostatistically signiﬁcant differences (pN0.05) compared with the
control assay, with no cytotoxic capacity in relation to blood
leukocytes (Fig. 3).3.7. Effect of treatment with F1, sodium diclofenac, and L-NAME on
leukocyte inﬂux and on nitrite production in the articular lavage ﬂuid
After 6 h of zymosan (Zy) induction, the treated groups were able
to reduce leukocyte inﬂux in the articular lavage ﬂuid. Of the groups
treated with F1, the group with 25 mg/kg showed less reduction
(52.1%) in cell inﬁltrate (pb0.05). The groups at F1 at 50 mg/kg and
75 mg/kg had signiﬁcant reductions (pb0.001) in the number of total
leukocytes in the articular lavage ﬂuid (83.5% and 96.7%, respectively),
comparedwith the positive control (Fig. 4A). No signiﬁcant differences
were observed between the results of group F1 at 50 mg/kg and the
groups treated with nonsteroidal anti-inﬂammatory drugs (NSAID)
and with L-NAME (pN0.05). The two latter groups also demonstrated
signiﬁcant action against leukocyte inﬂux, with diclofenac and
L-NAME showing an 83.3% and 80.1% decrease in inﬂux (pb0.001),
respectively.
Treatment with F1 at the different concentrations (25, 50, and
75 mg/kg), sodium diclofenac (5 mg/kg), and L-NAME (25 mg/kg)
(Fig. 4B) reduced (pb0.001) nitrite and nitrate production in the
articular lavage ﬂuid collected in the 6th h of induced inﬂammation
compared with the group that only received intra-articular zymosan.
The group treated with F1 (50 mg/kg) showed a greater effect (39%)
on NO inhibition compared with the groups treated with 25 mg/kg
(27.2%) and 75 mg/kg (33.1%) of F1. The treatment with F1 reduced
Fig. 3. The cytotoxicity assay of F1 sulfated fucan from L. variegata.
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dependent manner. The action of the fucan was similar to that of
sodium dicoﬂenac (37.5%). The action of L-NAME (50.7%) showed
greater nitrite reduction.3.8. Effect of treatment with F1, sodium diclofenac, and L-NAME on the
articular edema of rats submitted to zymosan-induced arthritis(ZyA)
Animals from the negative control group (intra-articular saline)
showed constant knee thickness. The positive group (50 μL of ZyFig. 4. A—Effect of F1 fucans from L. variegata on the number of leukocytes in samples of
synovial ﬂuid from animals submitted to zymosan-induced arthritis (20 μg/μL).
***Pb0.001/**Pb0.01 compared to the positive control group. B—Analysis of nitric
oxide in the synovial ﬂuid of animals. S represents the group that received saline i.a.
(negative control). Zy represents the group that received zymosan i.a. (positive
control). F1 (25, 50 and 75 mg/kg), D (5 mg/kg of sodium diclofenac), and 25 mg/kg of
L-NAME ***=Pb0.001.20 μg/μL i.a.) exhibited statistical differences from the negative
control group, with pb0.001 between 1 and 96 h after induction
(Fig. 5A).
The group treated with F1 at 25 mg/kg was not efﬁcient in
diminishing edema (Fig. 5B). The concentrations of 50 (pb0.01) and
75 mg/kg (pb0.001) of F1 reduced the edema on the 2nd and 3rd days
of treatment (Fig. 5C and D).
The treatment with a 50 mg/kg dose of polysaccharide from
L. variegata reduced the articular edema 24 h after induction compared
with the positive control group under the same conditions (pb0.001).
Comparedwith the edema1 h after induction, the F1 group at 50 mg/kg
diminished the edema by 63.4% in the 24th h and 94.5–100% after the
48th h, remaining so until the end of the experiment (5th day). The F1
group at 50 mg/kg showed a decrease in edema similar to that exhibited
by the group of animals treated with 5 mg/kg of sodium diclofenac
(Fig. 5E). The F1 groupwith 75 mg/kg diminished the edema by11.8% in
the24th h andby100%after the48th h, remaining so until the endof the
experiment (5th day), showing a decrease in edema on the 3rd day of
treatment (pb0.001). The groups treated with sodium diclofenac
(5 mg/kg) and L-NAME (25 mg/kg) (Fig. 5F) demonstrated signiﬁcant
effects (pb0.001) in the 24th h and 48th h, respectively.
Assessment of serum TNF-α cytokine was determined from the
blood serum samples of animals from different experimental groups
using the ELISA method. Comparison between the negative and
positive control groups (Fig. 6A) demonstrated a statistically
signiﬁcant difference (pb0.001) on the 5th experimental day. A slight
drop in TNF-α levels was observed in the group treated with F1
(Fig. 6B). The group treated with diclofenac showed no signiﬁcant
differences in TNF-α concentration (Fig. 6C), while the group treated
with L-NAME had decreased serum TNF-α (pb0.001) after 72 h of
experiment (Fig. 6D).
3.9. Hematoxylin and eosin staining (H&E) and immunohystochemistry
The histological ﬁndings then underwent semiquantitative analysis
(n=6), where ﬁbrous tissue, adipose tissue, cell inﬁltrate, capsular
integrity, and giant cells were analyzed in terms of abundance and
attributed scores as follows: 0 = absent, 1 = slight presence, 2 =
moderate presence, and 3 = marked presence. The effect of F1 from
L. variegata on histopathological parameters was determined in the
synovial membranes of Wistar rats submitted to 96 h (5 days) of
experiment and treated until the 4th day against zymosan-induced
articular inﬂammation (Table 2). The semi-quantitative analyses of
slides evaluated the following histopathological parameters of each
experimental group: cellular inﬁltrate, number of adipocytes, synovial
capsule degradation, ﬁbrinoid deposits, and giant cells. A score was
attributed to each parameter analyzed. Table 2 shows a marked
presence of cellular inﬁltrate in the zymosan group (score 3) and F1
(score 1). Capsular integrity (score 1) was the same to L-NAME, F1
(50 mg/mL), diclofenac. This conﬁrmed the pro-inﬂammatory effect of
zymosan and anti-inﬂammatory action of F1.
Analysis of the negative control (synovial membranes of animals
that received only intra-articular saline) (Fig. 7A), showed the presence
of a large number of lipid-storing cells (adipocytes) (score 3), normal
synovial capsule (1–4 cell layers and without villosities) (score 3), little
ﬁbrous tissue between the adipocytes (score 1), and no element that
indicated a chronic immune reaction, such as giant cells (score 0). In the
positive control (animals submitted to zymosan-induced inﬂamma-
tion), few or no adipocytes (score 0), abnormal synovial capsule
(score 1), a large amount of ﬁbrous tissue (score 3), and elements that
characterize reaction of the local immunological systemwere observed,
such as cell inﬁltrate and giant cells (Fig. 7B and C). Fig. 7D shows the
F1-treated synovial membrane submitted to the zymosan-induced
inﬂammatory process, clearly demonstrating the previously mentioned
decrease in inﬂammatory parameters. This can also be observed in the
histological analyses of animal membranes treated with sodium
Fig. 5. A—Assessment of knee edema in Wistar rats submitted (Zy i.a.) and not submitted (saline i.a.) to induced arthritis. ***=Pb0.001. B—Wistar rats submitted (Zy i.a. and
treated with 25 mg/kg of F1) and not submitted (saline i.a.) to induced arthritis. ***=Pb0.001. C—Assessment rats submitted (Zy i.a. and treated with 50 mg/kg of F1) and
not submitted (saline i.a.) to induced arthritis. ***=Pb0.001. D—rats submitted (Zy i.a. and treated with 75 mg/kg of F1) and not submitted (saline i.a.) to induced
arthritis. ***=Pb0.001.
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the 1st h and until the 4th day of Zymosan-induced arthritis (ZyA),
group 1 animals were treated with 50 mg/kg; after which they were
killed on the 5th day. Histopathological analysis of the synovia showed
an inﬂammatory exudate of polymorphonuclear (PMNs) cells (score 1)
and a large amount of adipose tissue (score 2); however, ﬁbrous tissue
was found in few regions (score 2). Histopathological analysis of the
membranes of sodium diclofenac-treated animals (5 mg/kg) showed
little PMN inﬁltrate (score 1). The L-NAME-treated animals (25 mg/kg)
also exhibited few PMNs (score 1). The efﬁcacy of F1 is evidenced by the
decrease in synovial inﬂammatory parameters, such as decreased
leukocyte inﬁltrate, increased synovial capsule integrity, and increased
number of adipocytes. The reduced inﬂammatory process was con-
ﬁrmed by histopathological and immunohistochemistry analyses,
which showed a decrease in cell inﬁltrate in the synovial membrane
and consequent reduction in TNF-α expression in saline, F1, AINES, and
L-NAME (Fig. 8A, C, D, and E). Analyses of immunohystochemistry
(TNF-α) of the negative control (synovial membranes of animals that
received only intra-articular saline) (Fig. 8A) showed a low level of these
cytokines. Although TNF-α had been detected in a high level in tissues
with zymosan induced (Fig. 8B),we observed a low level in the ratswith
F1 fraction (Fig. 8C), dicofenac (Fig. 8D), and L-NAME (Fig. 8E). These
proﬁles suggest an immunocellular response by F1 during the acute
phase. TNF-α levels are associated with the severity of the inﬂamma-tion. TNF-α is produced mainly by monocyte macrophages stimulated
with zymosan and other agents such as lipopolysaccharide (LPS).
4. Discussion
Brown seaweeds have been extensively studied since the
discovery of chemical components and immune response modulators
involving inﬂammatory response mechanisms in experimental
models. This study focused on the brown seaweed L. variegata and
the therapeutic action of its fucans and their puriﬁed fractions with
acetone on zymosan-induced arthritis.
The study of the brown seaweed L. variegata revealed the signiﬁcant
presence of carbohydrates and small amount of proteins. Fraction F1
showed a reasonable amount of sulfate and the presence of galactose,
fucose, and glucose. NMR 13C spectroscopic analysis revealed signals
related to 1→3 galactose bonds (103.2 ppm) and fucosemethyl groups
(15.9 ppm). Infrared analysis demonstrated bands related to the sulfate
clusters (1230 and 851 cm−1) in addition to the characteristic bands of
the hydrogen–oxygen bond (3210 cm−1). Different analysis methods
showed the antioxidant properties of fucans from F1, which are capable
of reducing and removing reactive oxygen species, such as superoxide
anions andhydroxyl radicals.We suggest that if possible thehigh results
obtained could be overestimated because of high viscosity of polysac-
charide solutions.
AB
C
Fig. 6. A—Assessment of serum TNF-α during the 5-day experiment. The saline groupwas
composed of the animals that only received intra-articular saline. The Zy group consisted of
theanimals that received intra-articular zymosan ***=Pb 0.001. B—TheF1groupconsisted
of the animals treated with 50mg/kg of F1 from L. variegata and 5 mg/kg of sodium
diclofenac. ***=Pb0.001. C—Group was composed of animals treated with 5 mg/kg of
sodium diclofenac. ***=Pb0.001. C–The L-NAME group consisted of animals treated with
25 mg/kg of this non-selective inhibitor of NOS. ***=Pb0.001.
Table 2
Scores for each parameter used in the histopathological analysis of the synovial ﬂuids.
Groups Cell
inﬁltrate
Adipocytes Fibrous
tissue
Capsular
integrity
Giant
cells
Saline 0 3 1 3 0
Zy 3 0 3 1 1
F1(50 mg/kg) 1 2 2 2 0
Diclofenac 1 3 2 2 0
L-NAME 1 3 2 2 0
1248 A.A.O. Paiva et al. / International Immunopharmacology 11 (2011) 1241–1250Several studies have shown that Zy arthritis in its chronic phase
displays a progressive synovitis that mimics the rheumatoid pannus.
In arthritis, perpetuation of the inﬂammatory process is attributed to
pro-inﬂammatory cytokines such as TNF-α and IL1-β, known
initiators of the NF-kappa B activation pathway (31). In addition topromoting pro-inﬂammatory gene expression via NF-Kappa B, TNF-α
also stimulates NADPH oxidase, the enzyme responsible for producing
the superoxide in the respiratory chain (32). This free radical has been
shown to be amediator of tissue damage in rheumatoid arthritis along
with pro-inﬂammatory cytokines. It was experimentally conﬁrmed
that the excessive production of reactive oxygen species can lead to
accelerated articular cartilage damage and osteoclast activation (33).
Oxide-reducer analysis of F1 revealed a possible blocking mechanism
in the ampliﬁed inﬂammatory process and signiﬁcant antioxidant
activity.
A number of studies have shown the capacity of fucosylated
compounds to inhibit endothelial rolling of leukocytes, attributed to
binding with P and L selectins. This property is due to the capacity of
fucosylated compounds to compete with a natural ligand of selectin,
Sialyl Lewis X (Slex), which is a fucosylate tetrasaccharide (34).
In a 6 h experiment, the decrease in cell inﬂux showed a strong
correlation with the amount of nitric oxide in the ﬂuid. In this
experimental model of zymosan-induced arthritis, the neutrophils are
responsible, at least partially, for NO production, likely because of the
increased expression of nitric oxide synthase (iNOS) in these cells
(35). In this study it was demonstrated that post-treatment with F1,
sodium diclofenac, and L-NAME signiﬁcantly inhibited cell inﬂux and
NO release in ZyA. Comparing the activity of both, we observed similar
action between 5 mg/kg of diclofenac and 50 mg/kg of F1. This result
indicates that F1 has a signiﬁcant anti-inﬂammatory effect in this
experimental model, similar to that of the reference drug. The use of
F1, diclofenac, and L-NAME also signiﬁcantly decreased NO, showing
no signiﬁcant differences among these groups. Some studies report
that low NO concentrations may protect immune system cells, such as
macrophages, from death, whereas excessive NO production may
cause cell death (36). Nitric oxide may not only cause inﬂammation
but also stimulate the enzymatic action of cyclooxygenase, increasing
prostaglandin production. Some prostaglandins (e.g., prostaglandin
E2) increase vascular permeability, thereby facilitating leukocyte
diapedesis (37,38).
After the96 hexperiment, theedemaandTNF-α concentrationwere
evaluated in each of the different groups. The zymosan group promoted
signiﬁcant edema during the 96 h of the experiment. Of the F1
concentrations only 50 and 75 mg/kg F1 exhibited an anti-edematous
effect. The use of 50 mg/kg of F1 and 5 mg/kg of sodium diclofenac
signiﬁcantly decreased the edema after 24 h, remaining so until the end
of the experiment (5th day). It was observed that 75 mg/kg of F1 and
L-NAME signiﬁcantly reduced edema after 48 h. Analysis of serum
TNF-α demonstrated an increase in this cytokine of the zymosan group
and a decrease in the F1 and L-NAME groups. Administration of 5 mg/kg
of sodium diclofenac did not signiﬁcantly alter TNF-α concentration
over the course of the experiment. One of the functions of TNF-α is to
induce the secretion of other inﬂammatory cytokines with paracrine
function, such as IL-1 and IL-6, in addition to strengthening its autocrine
secretion (39–41).
Keffer et al., 1991 studied transgenic mouse lines with hyper-
expression of one human TNF-α gene (with consequent increased
production of TNF-α). The authors observed that the animals
Fig. 7. Hystochemical of assay of F1 sulfated fucan from L. variegata. A—Analysis of the negative control (synovial membranes of animals that received only intra-articular saline).
B—Synovial membranes cell inﬁltrate. C—Shows giant cells. D—Shows the F1-treated synovial membrane submitted to the zymosan-induced inﬂammatory process. E and F—-
Histopathological cuts of the synovial membranes of animals submitted to Zy-induced arthritis and treated during the experiment with diclofenac and L-NAME (original
magniﬁcation: ×40).
Fig. 8. Immunohystochemical TNF-α assay of F1 sulfated fucan from L. variegata. A—Negative control (intra-articular saline); B—Shows positive control (intra-articular zymosan).
C—Shows the synovial membrane submitted to the zymosan-induced inﬂammatory process treated with F1. D—Shows synovial membranes of animals treated with diclofenac
(original magniﬁcation: ×40). E–Synovial membranes of animals treated with L-NAME.
1249A.A.O. Paiva et al. / International Immunopharmacology 11 (2011) 1241–1250spontaneously developed destructive arthropathy and inﬂammation
similar to that of rheumatoid arthritis (42).
The reduced inﬂammatory process was conﬁrmed by histopath-
ological and immunohistochemistry analyses, which showed adecrease in cell inﬁltrate in the synovial membrane and consequent
reduction in TNF-α expression. In summary, these results suggest that
the sulfated polysaccharides contained in fraction F1 of the seaweed
L. variegata exhibit antioxidant power and anti-inﬂammatory activity
1250 A.A.O. Paiva et al. / International Immunopharmacology 11 (2011) 1241–1250in animals with zymosan-induced arthritis, indicating a possible
redox modulation mechanism exercised by fucosylated and sulfated
saccharide compounds in this pathology.
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